Literature DB >> 4544451

Ototoxicity studies with BB-K8, a new semisynthetic aminoglycoside antibiotic.

J C Reiffenstein, S W Holmes, G H Hottendorf, M E Bierwagen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4544451     DOI： 10.7164/antibiotics.26.94

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  10 in total

1.  Comparative ototoxicity of amikacin and gentamicin in cats.

Authors:  E F Christensen; J C Reiffenstein; H Madissoo
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

2.  Ototoxicity of amikacin.

Authors:  R E Black; W K Lau; R J Weinstein; L S Young; W L Hewitt
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

3.  [Ototoxicity of the aminoglycoside antibiotics (author's transl)].

Authors:  P Federspil
Journal:  Infection       Date:  1976       Impact factor: 3.553

4.  Amikacin (BB-K8) treatment of multiple-drug resistant Proteus infections.

Authors:  P M Sharp; C A Saenz; R R Martin
Journal:  Antimicrob Agents Chemother       Date:  1974-05       Impact factor: 5.191

5.  Comparative in vitro activity of three aminoglycosidic antibiotics: BB-K8, kanamycin, and gentamicin.

Authors:  P K Yu; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1973-08       Impact factor: 5.191

6.  Comparative uptake of gentamicin, netilmicin, and amikacin in the guinea pig cochlea and vestibule.

Authors:  D Dulon; J M Aran; G Zajic; J Schacht
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

7.  Cochlear toxicity of butikacin (UK-18,892), a new semisynthetic aminoglycoside antibiotic, in guinea pigs.

Authors:  A J Carter
Journal:  Antimicrob Agents Chemother       Date:  1979-09       Impact factor: 5.191

8.  Newer aminoglycosides--amikacin and tobramycin: an in-vitro comparison with kanamycin and gentamicin.

Authors:  A V Reynolds; J M Hamilton-Miller; W Brumfitt
Journal:  Br Med J       Date:  1974-09-28

9.  Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations.

Authors:  Igor Nudelman; Annie Rebibo-Sabbah; Marina Cherniavsky; Valery Belakhov; Mariana Hainrichson; Fuquan Chen; Jochen Schacht; Daniel S Pilch; Tamar Ben-Yosef; Timor Baasov
Journal:  J Med Chem       Date:  2009-05-14       Impact factor: 7.446

Review 10.  Targeting Antibiotic Resistance.

Authors:  Mathieu F Chellat; Luka Raguž; Rainer Riedl
Journal:  Angew Chem Int Ed Engl       Date:  2016-03-22       Impact factor: 15.336
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.